Breadcrumb

Jennifer A. Kanakry, M.D.

Jennifer A. Kanakry, M.D.

  • Center for Cancer Research
  • National Cancer Institute

RESEARCH SUMMARY

Dr. Jennifer Kanakry engages in clinical research related to allogeneic hematopoietic cell transplantation for patients with hematologic malignancies and inherited and acquired disorders of the immune system. Transplant is potentially curative for these patients and Dr. Kanakry’s research is aimed at finding novel ways to make transplant less toxic, more effective, and more available to patients with these diseases. Dr. Kanakry also focuses her clinical research on viral complications of transplant and the kinetics of immune reconstitution. Dr. Kanakry leads several clinical trials at the NCI of allogeneic hematopoietic cell transplantation and of virus-specific cytotoxic T cell therapies, with a focus on peripheral T cell lymphomas and hematologic malignancies in patients living with HIV.

Areas of Expertise

1) allogeneic blood or marrow transplantation 2) virus-associated lymphomas and lymphoproliferative diseases 3) hematologic malignancies 4) primary immunodeficiency diseases 5) posttransplantation cyclophosphamide 6) alternative donor (haploidentical) bone marrow transplantation

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.

NIH Hematology Oncology Fellowship

Learn more about our unique training program focusing on hematologic and oncologic diseases.

Clinical Trials

Publications

Selected Key Publications

International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome

Dimitrova, D, Nademi, Z, Maccari, ME, Ehl, S, Uzel, G, Tomoda, T, Okano, T, Imai, K, Carpenter, B, Ip, W, Rao, K, Worth, AJJ, Laberko, A, Mukhina, A, Neven, B, Moshous, D, Speckmann, C, Warnatz, K, Wehr, C, Abolhassani, H, Aghamohammadi, A, Bleesing, JJ, Dara, J, Dvorak, CC, Ghosh, S, Kang, HJ, Markelj, G, Modi, A, Bayer, DK, Notarangelo, LD, Schulz, A, Garcia-Prat, M, Soler-Palacin, P, Karakukcu, M, Yilmaz, E, Gambineri, E, Menconi, M, Masmas, TN, Holm, M, Bonfim, C, Prando, C, Hughes, S, Jolles, S, Morris, EC, Kapoor, N, Koltan, S, Paneesha, S, Steward, C, Wynn, R, Duffner, U, Gennery, AR, Lankester, AC, Slatter, M and Kanakry, JA
J Allergy Clin Immunol. [Epub ahead of print] , 2021.
Full-Text Article
[ Journal Article ]

Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases

Dimitrova, D, Gea-Banacloche, J, Steinberg, SM, Sadler, JL, Hicks, SN, Carroll, E, Wilder, JS, Parta, M, Skeffington, L, Hughes, TE, Blau, JE, Broadney, MM, Rose, JJ, Hsu, AP, Fletcher, R, Nunes, NS, Yan, XY, Telford, WG, Kapoor, V, Cohen, JI, Freeman, AF, Garabedian, E, Holland, SM, Lisco, A, Malech, HL, Notarangelo, LD, Sereti, I, Shah, NN, Uzel, G, Zerbe, CS, Fowler, DH, Gress, RE, Kanakry, CG and Kanakry, JA
Biol Blood Marrow Transplant. 26/1: 94-106, 2020.
Full-Text Article
[ Journal Article ]

Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation

Acevedo, MJ, Wilder, JS, Adams, S, Davis, J, Kelly, C, Hilligoss, D, Carroll, E, Blacklock-Schuver, B, Cole, K, Kang, EM, Hsu, AP, Kanakry, CG, Dimitrova, D and Kanakry, JA
Biol Blood Marrow Transplant. 25/8: 1666-1673, 2019.
Full-Text Article
[ Journal Article ]

Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution

Melendez-Munoz, R, Marchalik, R, Jerussi, T, Dimitrova, D, Nussenblatt, V, Beri, A, Rai, K, Wilder, JS, Barrett, AJ, Battiwalla, M, Childs, RW, Fitzhugh, CD, Fowler, DH, Fry, TJ, Gress, RE, Hsieh, MM, Ito, S, Kang, EM, Pavletic, SZ, Shah, NN, Tisdale, JF, Gea-Banacloche, J, Kanakry, CG and Kanakry, JA
Biol Blood Marrow Transplant. 25/3: 577-586, 2019.
Full-Text Article
[ Journal Article ]

The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases

Kanakry, JA, Hegde, AM, Durand, CM, Massie, AB, Greer, AE, Ambinder, RF and Valsamakis, A
Blood. 127/16: 2007-2017, 2016.
Full-Text Article
[ Journal Article ]

Team

Research Nurse (Transplant Coordinator)
Amy Chai, RN, MSN
Patient Care Coordinator (Contr.)
Paola Massa, B.S.
Clinical Fellow
Kamil Rechache, M.D.
Transplant Coordinator
Melissa Walker, RN, BSN
Research Nurse
Jessenia Campos, RN, BSN, OCN
Patient Care Coordinator
Sherri Janzen, A.S.
Clinical Fellow
Krithika Shanmugasundaram, M.D.